|
Facebook
Twitter
Linkedin
|
 |
 |
 |
 |
Healthcare Company News 
VirtualScopics VirtualScopics' Scientists to Present at ISMRM 17th Scientific Meeting and Exhibition
VirtualScopics VirtualScopics' Scientists to Present at ISMRM 17th Scientific Meeting and Exhibition
VirtualScopics' Scientists to Present at ISMRM 17th Scientific Meeting and Exhibition
Friday, 17 April 2009 02:32 | 
| Company News - VirtualScopics |
VirtualScopics' Presents at ISMRM 17th Scientific Meeting and Exhibition on April 18 - April 24, 2009 in Honolulu, Hawaii
VirtualScopics, Inc. , a leading provider of quantitative imaging for clinical trials, announced today that Drs. Edward Ashton and Jonathan Riek will be among the invited presenters at the International Society for Magnetic Resonance in Medicine (ISMRM) 17th Scientific Meeting and Exhibition scheduled in Honolulu, Hawaii from April 18 - April 24, 2009.
Dr. Ashton, chief scientific officer at VirtualScopics, will present a paper entitled "Early DCE-MRI Findings Predict Tumor Volume Changes" on Tuesday, April 21, 2009 at 5:10 PM (HST). Dr. Ashton will also present a second paper, "Quantitative MR in Multi-Center Clinical Trials" as part of the Imaging Biomarker Educational Course on Thursday, April 23, 2009 at 1:30 PM (HST).
Dr. Riek, VirtualScopics' vice president of technology and product development, will present "Use of a Dual-Echo Fast-Spin-Echo Sequence for T2 Mapping of Cartilage within a Clinical Trial" during the poster session at 2:30 PM (HST) on Thursday, April 23, 2009.
"Dr. Riek and I are proud to have been selected to speak at the upcoming ISMRM meeting," stated Dr. Ashton. He added, "VirtualScopics is working at the forefront of MR imaging's applications in clinical trials and has witnessed first-hand the benefits of quantitative MR imaging in the drug development arena. Therefore, we greatly appreciate ISMRM's continued support and determination in furthering the research, development, and education in the field of MR imaging."
About VirtualScopics, Inc.
VirtualScopics, Inc. is a leading provider of imaging solutions to accelerate drug and medical device development. VirtualScopics has developed a robust software platform for analysis and modeling of both structural and functional medical images.
Source: VirtualScopics, Inc.
Dr. Ashton, chief scientific officer at VirtualScopics, will present a paper entitled "Early DCE-MRI Findings Predict Tumor Volume Changes" on Tuesday, April 21, 2009 at 5:10 PM (HST). Dr. Ashton will also present a second paper, "Quantitative MR in Multi-Center Clinical Trials" as part of the Imaging Biomarker Educational Course on Thursday, April 23, 2009 at 1:30 PM (HST).
Dr. Riek, VirtualScopics' vice president of technology and product development, will present "Use of a Dual-Echo Fast-Spin-Echo Sequence for T2 Mapping of Cartilage within a Clinical Trial" during the poster session at 2:30 PM (HST) on Thursday, April 23, 2009.
"Dr. Riek and I are proud to have been selected to speak at the upcoming ISMRM meeting," stated Dr. Ashton. He added, "VirtualScopics is working at the forefront of MR imaging's applications in clinical trials and has witnessed first-hand the benefits of quantitative MR imaging in the drug development arena. Therefore, we greatly appreciate ISMRM's continued support and determination in furthering the research, development, and education in the field of MR imaging."
About VirtualScopics, Inc.
VirtualScopics, Inc. is a leading provider of imaging solutions to accelerate drug and medical device development. VirtualScopics has developed a robust software platform for analysis and modeling of both structural and functional medical images.
Source: VirtualScopics, Inc.
